Who has invested in ImmunoGen?

No investors are named on the public record for ImmunoGen yet.

ImmunoGen Funding: $300M Raised, IPO

ImmunoGen funding overview

ImmunoGen is based in Waltham. ImmunoGen has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO.

ImmunoGen at a glance

Total raised: $300M
Latest round: IPO
Headquarters: Waltham

Frequently asked about ImmunoGen funding

How much has ImmunoGen raised?: ImmunoGen has raised $300M in total disclosed funding across the rounds on record.
Who has invested in ImmunoGen?: No investors are named on the public record for ImmunoGen yet.
What was the latest ImmunoGen funding round?: The most recent disclosed round is an IPO.
Where is ImmunoGen based?: ImmunoGen is based in Waltham.

We update the ImmunoGen record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Waltham and their backers are listed below.

ImmunoGen Funding: $300M Raised, IPO

ImmunoGen funding overview

ImmunoGen at a glance

Frequently asked about ImmunoGen funding

Companies related to ImmunoGen (18)

Browse related funding lists (2)